Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely tuned to replicate the characteristics of specific tissues so that the cells experience and engage with a realistic 3D environment. If you have interests in Biogelx 3D cell culture systems we would be delighted to talk to you, there is no cost to exploring potential opportunities. Tel: +44 (0) 1698 534655 Email: info@biogelx.com www.biogelx.com
View Top Employees from BiogelxWebsite | http://www.biogelx.com |
Revenue | $1 million |
Funding | $1 million |
Employees | 7 (7 on RocketReach) |
Founded | 2012 |
Phone | +44 1698 534655 |
Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Biopharma, Pharmaceuticals, Healthcare, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 8 Million |
Keywords | Bio Printing Regulations, How To Overcome 3d Bioprinting Challenge, Top Organ Bioprint, 3d Bioprinting Predictions, Hydrogel Biotechnology |
Competitors | Aquila Diagnostic Systems Inc., CollPlant, Contura Inc, Quad Technologies, mOasis |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies |
Looking for a particular Biogelx employee's phone or email?
The Biogelx annual revenue was $1 million in 2024.
7 people are employed at Biogelx.
The NAICS codes for Biogelx are [541, 5417, 54171, 54, 541713].
The SIC codes for Biogelx are [873, 87].